Skip to main content
OpenTrials
Completed

NCT Number: NCT06595264

Vein of Galen Aneurysm

1. Foundations of the clinical research project:

Vein of Galen vascular malformations are a group of rare cerebral vascular malformations with complex anatomy and severe clinical consequences. The pathology consists of direct communications between small intracerebral arteries and veins without the presence of capillaries. The result is a vascular malformation with low resistance and high flow, a lesion that will evolve during fetal development into aneurysmal dilatation.

These lesions evolve towards rupture, but due to the high flow rate through these malformations, children very quickly develop cardiac decompensation (high-output failure). Treatment must be rapid, often on the first day of life. The technique currently used is iterative embolization. General anaesthesia is required for this procedure. However, neonatal anesthesia in children with cardiac decompensation and pulmonary hypertension poses major challenges for the anesthesia team. A high percentage of these patients require a short stabilization period with management of cardiac decompensation and pulmonary hypertension, most often by continuous milrinone infusion.

Hôpital Erasme is a reference center for the management of vein of Galen malformations. In this work, we propose to analyze all cases of children with veins of Galen malformations managed by the interventional neuroradiology department. 2. Objectives of the clinical research project:

2.1 Main objective:

Description of cerebral lesions as described by angiography. Details of anesthetic management with all anesthetic drugs, details of cardiac management. Details of ventilatory management, intubation duration required.

Description of embolization outcome. Description of the neurological and cardiac outcome.

2.2 Secondary objectives:

Possibly, depending on the number of patients, attempt to identify factors predictive of poor outcome. 3. Methodology of the clinical research project:

We will carry out a retrospective analysis of the records of all patients who have been managed at Erasme for vein of Galen-type malformation. Activity began ± in 2011, and we will produce a listing of all patients from 2010 to August 2024. From this listing, obtained by the radiology department, we will collect data from the patients computer files. 4. Design of the clinical research project:

This is a retrospective study based on file analysis. 5. Participants:

All patients treated at Erasme for a vein of Galen malformation. We will check the file to ensure that the parents have not expressed any opposition to the use of the patient medical data.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients treated at Erasme for a vein of Galen malformation

Exclusion criteria

  • Opposition of parents to the use of medical data

Treatment and study plan

embolization therapy

Procedure

Embolization in the neuroradiological department is the Golden Standard for the treatment of vein of Galen malformations.

Primary outcomes

  1. Neurological outcome

    Time frame: 28 days

    Neurological outcome after each embolization therapy will be recorded (%): No neurological deficit, minor neurological deficit, major neurological deficit

Secondary outcomes

  1. Cardiac failure

    Time frame: 28 days

    Presence of cardiac failure before, during and after each embolization therapy will be recorded. (%)

  2. Inotropic support

    Time frame: 28 days

    Inotropic support for heart failure will be recorded (%), as well as the type of inotropic agents used for treatment and maximum dosage.

Sponsors and collaborators

Lead sponsor

Erasme University Hospital

Other

Registry information

Official study title

Patients With Aneurysms of the Vein of Galen, H.U.B Experience; a Retrospective Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Sep 19, 2024
Registry last updated
May 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.